Phare Bio Inc
Phare Bio Inc's latest filing in the PeerBasis snapshot reports a Part VII D + F figure of $563,402 for Akhila Kosaraju, Ceo & President (FY 2024). Column F can include amounts from the filing and related organizations.
After indexing supported filing years to 2025 comparison dollars, the subject figure is $578,227. It is higher than the D + F figure for 136 of 136 peer organizations selected under the disclosed tier Same NTEE major group (H), nationwide + size band 0.71–1.4× revenue (approximately 100%; median $167,618). This is descriptive, not a reasonableness conclusion.
Preparing executive-pay materials for this board?
Review the selected comparables for Phare Bio Inc, then prepare a source-linked report and bracketed documentation worksheet for the board to verify and complete.
Review the peer setSelected peer organizations
Actual selection tier: Same NTEE major group (H), nationwide + size band 0.71–1.4× revenue. Displayed D + F figures from supported filing years are indexed to 2025 comparison dollars with BLS CPI-U; a nationwide tier also uses 2024 BEA RPP as a consumer price-level proxy when both the subject and peer have supported state codes. Unsupported state codes receive no interstate adjustment. Comparison values can differ from the raw filing. Column F may include related-organization amounts.
| Organization | State | Revenue | D + F (2025 dollars) |
|---|---|---|---|
| The National Fragile X Foundation | DC | $2,134,157 | $141,664 |
| Ada Foundation | IL | $2,133,662 | $116,660 |
| Erase Ptsd Now | IL | $2,126,795 | $108,131 |
| Nevada Cancer Research Foundation | NV | $2,123,807 | $55,649 |
| Harmon Killebrew-danny Thompson | ID | $2,121,142 | $184,772 |
| The Leonard & Madlyn Abramson Family | PA | $2,181,553 | $69,328 |
| Texas Oncology Foundation Inc | TX | $2,112,896 | $223,008 |
| American Speech-language-hearing Foundation | MD | $2,108,854 | $261,374 |
View the organization record and available filings on ProPublica